Igeekphone July 7, 2026 – Pennsylvania has updated its list of Electronic Nicotine Delivery Systems (ENDS) Pending Certifications, with 23 manufacturers now undergoing state-level certification review.
The latest update includes several manufacturers with Chinese ties, including Shenzhen Smoore Technology Limited, Shenzhen IVPS Technology Co., Ltd., YME Technology Limited, and Boulder International, a company with research, development, and manufacturing operations connected to China.
The development marks another milestone in the implementation of Pennsylvania’s Act 57 of 2025, while also highlighting a broader shift in U.S. vaping regulation: state authorities are increasingly focusing on manufacturers—not just consumer-facing brands—as part of market access oversight.
Pennsylvania’s ENDS Directory Moves Into the Implementation Phase
Signed into law in late 2025, Act 57 of 2025 established Pennsylvania’s ENDS Directory, a state-level certification system governing the sale of e-cigarette products.
Under the legislation, manufacturers wishing to sell ENDS products in Pennsylvania must submit certification materials to the Pennsylvania Office of Attorney General. Only products approved through this process will be eligible for legal sale within the state.
The Attorney General officially launched the ENDS Directory website on June 20, publishing the first Pending Certifications list alongside it.
As of the latest update on June 26, no manufacturer had yet completed the certification process and entered the state’s official directory. Instead, all 23 listed manufacturers remain under review.
Beginning October 19, 2026, products not included in the official ENDS Directory will become subject to state enforcement measures, making the pending list an important indicator of future legal market access.
Unlike the U.S. Food and Drug Administration’s Premarket Tobacco Product Application (PMTA) process, which evaluates the scientific suitability of products before they enter the market, Pennsylvania’s ENDS Directory functions as a state-level market access system. Manufacturers must satisfy both federal and state regulatory requirements to continue selling products in Pennsylvania.
Chinese-Linked Manufacturers Gain Visibility
Among the manufacturers currently under review are several companies with Chinese operations or ownership, reflecting the significant role Chinese manufacturers continue to play in the global vaping supply chain.
Unlike previous regulatory efforts that often emphasized consumer brands, Pennsylvania’s certification process identifies the manufacturer as the primary regulatory entity.
One notable example is Shenzhen Smoore Technology Limited, which appears as the listed manufacturer for Logic, the vaping brand owned by Japan Tobacco International (JTI).
Another is Shenzhen IVPS Technology Co., Ltd., which is listed as the manufacturer behind SWFT, a disposable vape brand that has expanded rapidly in North America in recent years.
The OXBAR brand is represented by YME Technology Limited, a Hong Kong-registered company. Public records indicate that OXBAR products are operated by a Shenzhen-based company and that YME Technology has previously appeared as the responsible manufacturer for OXBAR products registered under the European Union’s Tobacco Products Directive (TPD) framework. Its appearance in Pennsylvania suggests the company is extending its compliance efforts into the U.S. regulatory system.
Meanwhile, Boulder International, listed as the manufacturer for both Boulder and Rock, represents a cross-border business model. While the company operates its brand and commercial activities in the United States, it maintains close ties to research, development, and manufacturing operations in Shenzhen. Boulder has also previously pursued FDA PMTA submissions for tobacco- and mint-flavored vaping products.
Regulation Expands Beyond Consumer Brands
For years, discussion surrounding U.S. vaping regulation has largely centered on consumer brands such as JUUL, Vuse, and NJOY, with attention focused on whether their products obtained FDA marketing authorization.
Pennsylvania’s ENDS Directory reflects a different regulatory approach.
Instead of concentrating solely on the brands visible to consumers, the state places regulatory responsibility directly on manufacturers, requiring them to submit certification materials and undergo review before their products can legally enter the market.
The shift suggests state regulators are extending oversight further upstream in the vaping supply chain, placing greater emphasis on manufacturing entities responsible for product production and compliance.
Growing Importance of State-Level Compliance
For manufacturers supplying the U.S. market, the evolving regulatory landscape presents new compliance challenges.
Meeting FDA requirements—including the PMTA process—remains essential. However, companies must now also monitor individual state certification systems, each of which may impose additional requirements for legal market access.
As more U.S. states establish ENDS directory programs, state-level compliance is becoming an increasingly important component of market strategy for both domestic and international manufacturers.
A Structural Shift in U.S. Vape Regulation
Pennsylvania’s updated Pending Certifications list offers more than a snapshot of companies currently under review—it reflects a broader transformation in the U.S. regulatory framework for vaping products.
In recent years, several states have introduced ENDS Directory systems that operate alongside FDA oversight, effectively creating an additional layer of state-level market regulation.
Pennsylvania, one of the largest states to implement such a system, is emerging as an important case study in how these policies may shape the future of the industry.
The participation of multiple Chinese-linked manufacturers also underscores the increasingly direct role global suppliers are playing within U.S. regulatory processes.
If similar directory systems continue to expand across the country, the U.S. vaping market could increasingly operate under a dual compliance model: federal scientific review through the FDA and state-level market access through ENDS directory certification. For manufacturers worldwide, success in the U.S. market may increasingly depend on navigating both regulatory pathways simultaneously.